Study Yields Neural Crest Cells from Adult Skin Cells, and Could Lead to New Treatments for Parkinson’s and Other Brain Illnesses

Published March 24, 2017

A discovery, several years in the making, by a University at Buffalo research team has proven that adult skin cells can be converted into neural crest cells (a type of stem cell) without any genetic modification, and that these stem cells can yield other cells that are present in the spinal cord and the brain. The results titled, “Reprogramming Postnatal Human Epidermal Keratinocytes Toward Functional Neural Crest Fates,” were recently published in the journal Stem Cells, were supported by grants from the National Institutes of Health.

The applications could be very significant, from studying genetic diseases in a dish to generating possible regenerative cures from the patient’s own cells. The identity of the cells was further confirmed by lineage tracing experiments, where the reprogrammed cells were implanted in chicken embryos and acted just as neural crest cells do.  Stem cells have been derived from adult cells before, but not without adding genes to alter the cells. The new process yields neural crest cells without addition of foreign genetic material. The reprogrammed neural crest cells can become smooth muscle cells, melanocytes, Schwann cells or neurons.

In addition to Dr. Stelios T. Andreadis, professor and chair of UB’s Department of Chemical and Biological Engineering, collaborators include; Dr. Gabriella Popescu, professor in the Department of Biochemistry in the Jacobs School of Medicine and Biomedical Sciences at UB; Dr. Song Liu, vice chair of biostatistics and bioinformatics at Roswell Park Cancer Institute and a research associate professor in biostatistics UB’s School of Public Health and Health Professions; and Dr. Marianne Bronner, professor of biology and biological engineering, California Institute of Technology.

“In medical applications this has tremendous potential because you can always get a skin biopsy,” Dr. Andreadis says. “We can grow the cells to large numbers and reprogram them, without genetic modification. So, autologous cells derived from the patient can be used to treat devastating neurogenic diseases that are currently hampered by the lack of easily accessible cell sources.”

The process can also be used to model disease. Skin cells from a person with a genetic disease of the nervous system can be reprogrammed into neural crest cells. These cells will have the disease-causing mutation in their chromosomes, but the genes that cause the mutation are not expressed in the skin. The genes are likely to be expressed when cells differentiate into neural crest lineages, such as neurons or Schwann cells, thereby enabling researchers to study the disease in a dish. This is similar to induced pluripotent stem cells, but without genetic modification or reprograming to the pluripotent state.

Dr. Andreadis credits the persistence of his then-PhD student, Mr. Vivek K. Bajpai, for sticking with it. “He is an excellent and persistent student,” Dr. Andreadis says. “Most students would have given up.” Dr. Andreadis also credits a seed grant from UB’s office of the Vice President for Research and Economic Development’s IMPACT program that enabled part of the work.

The work recently received a $1.7 million National Institutes of Health grant to delve into the mechanisms that occur as the cells reprogram, and to employ the cells for treating the Parkinson’s-like symptoms in a mouse model of hypomyelinating disease.

“This work has the potential to provide a novel source of abundant, easily accessible and autologous cells for treatment of devastating neurodegenerative diseases. We are excited about this discovery and its potential impact and are grateful to NIH for the opportunity to pursue it further,” Dr. Andreadis said.